Clinical trial · Interventional
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Carcinoma | Kidney Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DaVinci RAPN | Device | — | UNRESOLVED |
| Hugo RAS RAPN | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- DaVinci system
- description
- Robot-assisted partial nephrectomy is performed using the DaVinci platform
- interventionNames
- Device: DaVinci RAPN
- type
- EXPERIMENTAL
- label
- Hugo RAS system
- description
- Robot-assisted partial nephrectomy is performed using the Hugo RAS platform
- interventionNames
- Device: Hugo RAS RAPN
Primary outcomes (3)
- measure
- Number of participants with postoperative complications
- timeFrame
- Over the 4 days post surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * patient aged between 18 and 90 years old; * patient with localized kidney tumor suitable for partial nephrectomy; * patient able to understand and sign the informed consent; * patient compliance with the follow-up program. Exclusion Criteria: * patient who do not fall within the inclusion age range; * patient not suitable for partial nephrectomy; * patient unable to understand and sign the informed consent; * patient unable to follow the monitoring program; * patient refusal to participate to the study.
References
Publications (0)
Data not yet available